Latest Breaking News On - Medspray pharma - Page 1 : comparemela.com

Silo Pharma Concludes First Phase of Dose-Ranging Study Of Intranasal Treatment For Post Traumatic Stress Disorder

Thursday, Silo Pharma Inc (NASDAQ: SILO) provided an update on its previously announced dose-ranging study of SPC-15, a targeted prophylactic treatment for post-traumatic stress disorder (PTSD). In November, Silo Pharma announced a new exclusive license agreement with Medspray Pharma BV for its proprietary patented soft mist nasal spray technology, the delivery mechanism selected for Silo's intranasal therapeutic drug SPC-15. The study aims to identify the maximum tolerated intranasal dose of th

Eric weisblumSilo pharma incSilo pharmaMedspray pharmaChief executive officerInvestigational new drugStock market gameBenzinga proDay trialSilo pharma concludes first phasePharmacokinetic studyDose ranging studyToxicology studyTherapeutic drug

SHF Holdings And 3 Other Stocks Under $2 Insiders Are Buying - SHF Hldgs (NASDAQ:SHFS), Quince Therapeutics (NASDAQ:QNCX)

The Dow Jones closed higher by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Allan marshallDavid lamondEric weisblumDonald emmiHoldings incPharma incDow jonesUpexi incQuince therapeutics incSilo pharma incLegal officer donald emmiQuince therapeuticsQuince therapeutics doesLike it very muchSilo pharmaMedspray pharma

Silo Pharma, Medspray make deal for nasal spray delivery of PTSD, anxiety drug

Silo Pharma, Medspray make deal for nasal spray delivery of PTSD, anxiety drug
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Medspray pharmaHeather bieleEric weisblumColumbia universitySilo pharma

Silo Pharma (SILO) Enters Exclusive License Agreement with Medspray Pharma BV for Intranasal Technology used in SPC-15 Treatment for PTSD

Silo Pharma (SILO) Enters Exclusive License Agreement with Medspray Pharma BV for Intranasal Technology used in SPC-15 Treatment for PTSD
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eric weisblumSilo pharma incMedspray spray technologySilo pharmaMedspray pharmaSpray technologyChief executive officer

Silo Pharma Collaborates With Medspray Pharma For Intranasal Technology For Stress Disorder Candidate - SILO Pharma (NASDAQ:SILO)

Silo Pharma Inc (NASDAQ: SILO) announced a new exclusive license agreement with Medspray Pharma BV for its proprietary patented soft mist nasal spray technology, the delivery mechanism selected for Silo's intranasal therapeutic drug SPC-15.

Eric weisblumPharma incColumbia universityMedspray spray technologyMedspray pharmaSpray technology